Business · 27/02/2017
FDA Announces Public Workshop on Animal Models for Acinetobacter baumannii and Pseudomonas aeruginosa Infections
The FDA is hosting a public workshop to discuss the current state and future development of animal models for treating serious infections caused by these bacteria, with the goal of facilitating the creation of narrow-spectrum antibacterial drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →